- Decrease font
- Increase font
- Send to a friend
Click here to bookmark this page
Customize your Bookmarks:
- Type the name of the page the way you would like it to appear in "My Bookmarks";
- Click in the "Add as My Bookmarks" button.
To choose your favorite sessions, please click here.
NOTICE TO THE MARKET
CENTRO DE IMAGEM DIAGNÓSTICOS S.A. ("Company" or "Alliar"), pursuant to paragraph 4 of article 157 of Law 6,404/76 and Instruction 358/02 of the Brazilian Securities and Exchange Commission ("CVM"), updates its shareholders and the market in general on the scenario arising from the pandemic of the novel coronavirus (COVID-19).
The Company informs that today it reached the milestone of 80,000 tests performed to diagnose COVID-19. It includes the three main methodologies: RT-PCR, rapid tests, and serological tests.
The Company continues to monitor the effects of the COVID-19 pandemic and will keep its shareholders and the market in general informed of additional initiatives and new developments related to this topic.
CEO and Investor Relations Officer